You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

IL-6/IL-6 receptor pathway

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

IL- 6 Gene Single Nucleotide Polymorphism asIndicator of

Completed
  • Covid19
  • interleuken 6 level measurment
  • Interleukin-6 Gene-174C detection
  • Tanta, El Gharbyia, Egypt
    Bsant Safwat Kasem
May 1, 2022

IL-6 in Synovial Fluid in Obese and Normal Weight Patients

Recruiting
  • IL-6 Concentration in the Synovial Fluid of Obese Patients is 100% Higher Than the IL-6 Concentration of the Synovial Fluid in Normal Weight Patients
  • Evaluation of IL-6 biomarkers in synovial fluid
  • Milan, Italy
    IRCCS Istituto Ortopedico Galeazzi
Nov 25, 2021

Malignant Pleural Effusion, Malignant Ascites Trial in Pittsburgh (Tocilizumab)

Not yet recruiting
  • Malignant Pleural Effusion
  • Malignant Ascites
  • Pittsburgh, Pennsylvania
    Allegheny Health Network Cancer Institute
Aug 30, 2023

Kidney Transplantation, Graft Failure Trial in Toulouse (Tocilizumab)

Recruiting
  • Kidney Transplantation
  • Graft Failure
  • Toulouse, France
    CHU Toulouse
Mar 15, 2022

Pulmonary Arterial Hypertension Trial in Japan (Satralizumab (Genetical Recombination))

Recruiting
  • Pulmonary Arterial Hypertension
  • Satralizumab (Genetical Recombination)
  • Chiba, Japan
  • +8 more
Jan 10, 2023

Covid19 Trial in Ribeirão Preto, Santo André (Ixekizumab, Aldesleukin, Colchicine)

Completed
  • Covid19
  • Ixekizumab
  • +3 more
  • Ribeirão Preto, SP, Brazil
  • +1 more
Jul 26, 2022

Adamantinomatous Craniopharyngioma, Recurrent Adamantinomatous Craniopharyngioma Trial in Worldwide (Tocilizumab)

Recruiting
  • Adamantinomatous Craniopharyngioma
  • Recurrent Adamantinomatous Craniopharyngioma
  • Aurora, Colorado
  • +17 more
Jan 8, 2023

Low Back Pain Trial in Islamabad (• Blood Markers CRP, TNFa, IL-6, IL-8, IL-1, and IL-1ß AND FIBRINOGEN)

Not yet recruiting
  • Low Back Pain
  • • Blood Markers CRP, TNFα, IL-6, IL-8, IL-1, and IL-1β AND FIBRINOGEN
  • Islamabad, Pakistan
    KRL Hospital
Feb 20, 2023

Rheumatoid Arthritis Trial in China (IL-6R Monoclonal Antibody Injection 4mg/kg, IL-6R Monoclonal Antibody Injection 6mg/kg,

Completed
  • Rheumatoid Arthritis
  • IL-6R Monoclonal Antibody Injection 4mg/kg
  • +3 more
  • Baoding, China
  • +4 more
Feb 24, 2022

Long COVID, POTS - Postural Orthostatic Tachycardia Syndrome, Autonomic Dysfunction Trial (IL-6, cytokines (IL-17, and IFN-?),

Not yet recruiting
  • Long COVID
  • +2 more
  • IL-6
  • +2 more
  • (no location specified)
Sep 6, 2023

Aneurysmal Subarachnoid Haemorrhage Trial in Zürich (CytoSorb)

Terminated
  • Aneurysmal Subarachnoid Haemorrhage
  • CytoSorb
  • Zürich, Switzerland
    University Hospital Zurich
Aug 3, 2022

Symphony IL-6 Reference Range Study

Recruiting
  • Sepsis
    • Dallas, Texas
      University of Texas Southwestern Medical Center
    Sep 9, 2021

    Study for Patients at Risk of Severe Sepsis

    Recruiting
    • Severe Sepsis
      • Dallas, Texas
        University of Texas Southwestern Medical Center
      Sep 17, 2021

      Study for Patients at Risk of Severe Sepsis

      Recruiting
      • Severe Sepsis
        • Dallas, Texas
          University of Texas Southwestern Medical Center
        Sep 9, 2021

        Chronic Granulomatous Disease Trial run by the NIAID (Sirolimus, Cyclophosphamide, Alemtuzumab)

        Recruiting
        • Chronic Granulomatous Disease
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jul 23, 2022

        MIP-1 Alpha and IL-6 in Saliva of Post Myocardial Infarction and

        Completed
        • Myocardial Infarction
        • Periodontal Diseases
        • salivary test
        • Mangalore, India
          AB shetty Institute of dental sciences
        Mar 29, 2022

        IL-6 as a Biomarker for Personalized Treatment of PR

        Completed
        • Rheumatoid Arthritis
          • Montpellier, France
            UH Montpellier
          Oct 18, 2021

          Intracerebral Haemorrhage Trial in Manchester (IL-1Ra Kineret®, IL-1Ra Placebo)

          Completed
          • Intracerebral Haemorrhage
          • IL-1Ra Kineret®
          • IL-1Ra Placebo
          • Manchester, North West, United Kingdom
            Salford Royal NHS Foundation Trust
          Oct 4, 2021

          COVID-19 Trial in Phoenix, Baltimore, New York (Clazakizumab 25 mg, Clazakizumab 12.5 mg, Placebo)

          Completed
          Has Results
          • COVID-19
          • Clazakizumab 25 mg
          • +2 more
          • Phoenix, Arizona
          • +2 more
          Jun 10, 2022

          COVID-19 Trial in Los Angeles (Clazakizumab)

          Completed
          Has Results
          • COVID-19
          • Los Angeles, California
            Cedars-Sinai Medical Center
          Nov 30, 2021

          Gingivitis Trial in Riyadh (Nigella Sativa oil, Chlorhexidine mouthwash)

          Completed
          • Gingivitis
          • Nigella Sativa oil
          • Chlorhexidine mouthwash
          • Riyadh, Saudi Arabia
            Princess Nourah bint Abdulrahman University Dental Clinic
          Sep 25, 2021

          Non-Hodgkin Lymphoma Trial in Columbus (Biospecimen Collection, Computed Tomography, Positron Emission Tomography)

          Recruiting
          • Non-Hodgkin Lymphoma
          • Biospecimen Collection
          • +3 more
          • Columbus, Ohio
            Ohio State University Comprehensive Cancer Center
          Jan 13, 2023

          Acute Myeloid Leukemia, Vitamin D Deficiency, ADAMTS13 Trial in Cairo (Cholecalciferol 2800 I.U. ml oral drops)

          Completed
          • Acute Myeloid Leukemia
          • +3 more
          • Cholecalciferol 2800 I.U. ml oral drops
          • Cairo, Madinaty, Egypt
            Dina Ashraf Abdelhady
          Nov 25, 2021

          CharacterisatiON of carDiac funCTion in Intensive Care Unit

          Not yet recruiting
          • Heart Failure
          • +3 more
          • CMR
          • +7 more
          • Glasgow, United Kingdom
          • +1 more
          Nov 21, 2022

          Non-Hodgkin Lymphoma, Relapsed/Refractory Diffuse Large B-cell Lymphoma Trial in United States (NKTR-255 at 1.5 µg/kg, NKTR-255

          Recruiting
          • Non-Hodgkin Lymphoma
          • Relapsed/Refractory Diffuse Large B-cell Lymphoma
          • NKTR-255 at 1.5 µg/kg
          • +3 more
          • La Jolla, California
          • +26 more
          Jan 10, 2023